• 1. Novel hole-transporting materials based on 1,4-bis(carbazolyl)benzene for organic light-emitting devices
  Qian Zhang,Jiangshan Chen,Yanxiang Cheng,Lixiang Wang,Dongge Ma,Xiabin Jing,Fosong Wang J. Mater. Chem. 2004 14 895
• 2. Scalable perovskite coating via anti-solvent-free Lewis acid–base adduct engineering for efficient perovskite solar modules
  Do-Kyoung Lee,Kwang-Soo Lim,Jin-Wook Lee,Nam-Gyu Park J. Mater. Chem. A 2021 9 3018
• 3. Design of star-shaped molecular architectures based on carbazole and phosphine oxide moieties: towards amorphous bipolar hosts with high triplet energy for efficient blue electrophosphorescent devices
  Junqiao Ding,Qi Wang,Lei Zhao,Dongge Ma,Lixiang Wang,Xiabin Jing,Fosong Wang J. Mater. Chem. 2010 20 8126
• 4. A cationic iridium(iii) complex showing aggregation-induced phosphorescent emission (AIPE) in the solid state: synthesis, characterization and properties
  Guo-Gang Shan,Ling-Yu Zhang,Hai-Bin Li,Shuang Wang,Dong-Xia Zhu,Peng Li,Chun-Gang Wang,Zhong-Min Su,Yi Liao Dalton Trans. 2012 41 523
• 5. Structural and mechanistic studies of the base-induced Sommelet–Hauser rearrangement of N-α-branched benzylic azetidine-2-carboxylic acid-derived ammonium salts
  Eiji Tayama,Kazutoshi Watanabe,Sho Sotome Org. Biomol. Chem. 2017 15 6668

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidones
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Pyrimidones
• Solvents and Organic Chemicals Organic Compounds Acids/Esters
• Solvents and Organic Chemicals Organic Compounds Hydrocarbons
• Solvents and Organic Chemicals Organic Compounds

Introduction to Tetrahydro-2(1H)-pyrimidinone (CAS No. 1852-17-1)

Tetrahydro-2(1H)-pyrimidinone, identified by its Chemical Abstracts Service (CAS) number 1852-17-1, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the pyrimidinone class, a structural motif that is widely recognized for its biological activity and potential therapeutic applications. The unique scaffold of Tetrahydro-2(1H)-pyrimidinone consists of a six-membered ring containing a nitrogen atom, further functionalized by a hydroxyl group and a tetrahydropyran ring, which contributes to its distinctive chemical and pharmacological properties.

The structural features of Tetrahydro-2(1H)-pyrimidinone make it a versatile intermediate in the synthesis of various bioactive molecules. Its pyrimidinone core is a common pharmacophore in drug discovery, often found in compounds with antimicrobial, antiviral, and anticancer activities. The presence of the tetrahydropyran ring enhances the compound's solubility and bioavailability, making it an attractive candidate for further development into therapeutic agents.

Recent advancements in computational chemistry and molecular modeling have shed new light on the pharmacological potential of Tetrahydro-2(1H)-pyrimidinone. Studies have demonstrated that this compound can interact with multiple biological targets, including enzymes and receptors involved in critical cellular pathways. For instance, research has shown that derivatives of Tetrahydro-2(1H)-pyrimidinone exhibit inhibitory effects on kinases, which are key players in cancer progression. These findings have prompted further investigation into its role as a lead compound for the development of novel anticancer therapies.

In addition to its oncology applications, Tetrahydro-2(1H)-pyrimidinone has shown promise in the treatment of neurological disorders. Preliminary studies indicate that this compound can modulate neurotransmitter release and receptor activity, suggesting its potential use in managing conditions such as epilepsy and neurodegenerative diseases. The ability of Tetrahydro-2(1H)-pyrimidinone to cross the blood-brain barrier is particularly noteworthy, as it allows for direct interaction with central nervous system (CNS) targets.

The synthesis of Tetrahydro-2(1H)-pyrimidinone involves multi-step organic reactions that highlight its synthetic utility. One common synthetic route includes the cyclization of ethyl acetoacetate with urea or thiourea under acidic conditions, followed by reduction to yield the tetrahydropyran derivative. Alternative methods involve the use of transition metal catalysts to facilitate ring formation and functionalization. These synthetic strategies underscore the compound's accessibility and suitability for large-scale production.

Industrial applications of Tetrahydro-2(1H)-pyrimidinone are also emerging, particularly in agrochemicals and specialty chemicals. Its structural framework can be modified to create compounds with herbicidal and fungicidal properties, offering new solutions for crop protection. Furthermore, its role as a building block in fine chemical synthesis underscores its versatility beyond pharmaceuticals.

The safety profile of Tetrahydro-2(1H)-pyrimidinone is another critical aspect that has been extensively studied. Toxicological assessments have revealed that this compound exhibits low acute toxicity when administered orally or intraperitoneally in animal models. However, chronic exposure studies are still needed to fully understand its long-term effects. These findings are crucial for guiding its safe use in both laboratory and industrial settings.

Future research directions for Tetrahydro-2(1H)-pyrimidinone include exploring its mechanism of action in greater detail and identifying new derivatives with enhanced biological activity. Advances in high-throughput screening technologies will likely accelerate the discovery process, enabling rapid identification of promising candidates for clinical development. Collaborative efforts between academic institutions and pharmaceutical companies are essential to translate these findings into tangible therapeutic benefits.

In conclusion, Tetrahydro-2(1H)-pyrimidinone (CAS No. 1852-17-1) is a structurally intriguing compound with broad applications in pharmaceuticals, agrochemicals, and specialty chemicals. Its unique properties make it an attractive scaffold for drug discovery, particularly in oncology and neurology. As research continues to uncover new therapeutic potentials, this compound is poised to play a significant role in addressing some of today's most pressing medical challenges.

• 623-95-0(N,N’-Dipropylurea)
• 2224-20-6(4-Methyl-1,3-diazinan-2-one)
• 38014-52-7(Urea,N-methyl-N'-propyl-)
• 32897-26-0(1-3-(Dimethylamino)propyl-3-ethylurea)
• 35674-65-8(Urea,N,N''-1,3-propanediylbis[N'-octadecyl-)
• 17496-93-4(2(1H)-Pyrimidinone,tetrahydro-5,5-dimethyl-)
• 13092-83-6(2(1H)-Pyrimidinone,tetrahydro-5-methyl-)
• 7226-23-5(1,3-dimethyl-1,3-diazinan-2-one)
• 627-06-5(Propylurea)
• 38014-56-1(Urea,N-ethyl-N'-propyl-)